Health
Vaccine by Christmas amid record cases in the US – News Mail
The Oxford vaccine trial has produced a positive response, as more than half US states reported their highest day of new cases.
A vaccine candidate for COVID-19 developed by the University of Oxford with the backing of pharmaceutical giant AstraZeneca has produced positive results.
The test jabs have triggered robust immune responses in adults.
According to Bloomberg, findings from blood tests which were carried out on a group of older trial participants reinforce data released in July which suggest the vaccine is effective for adults aged between 18 and 55, Astra announced on Monday local time.
Results from the study show…
-
Noosa News15 hours agoHow Lily Steele-Park took her rapist to court and won
-
General21 hours agoRush to buy homes before rate cuts send prices soaring
-
Business17 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Business20 hours agoFord CEO makes stunning prediction about artificial intelligence